Acute myeloid leukemia tag sponsored by:
Acute myeloid leukemia
-
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL / LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress |
wugen.com | | Article Details | Related Articles -
Actinium Highlights Mutation Data from the Phase 3 SIERRA Trial of Iomab-B and Novel Linker Technology to Support Solid Tumor Antibody Radiation Conjugate Development at the 2024 Society of Nuclear Medicine & Molecular Imaging Annual Meeting :: Actin
ir.actiniumpharma.com | | Article Details | Related Articles